| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 33 |
| 1 | ETANERCEPT | 28 |
| 2 | UPADACITINIB | 17 |
| 3 | ETONOGESTREL AND ETHINYL ESTRADIOL | 15 |
| 4 | DUPILUMAB | 14 |
| 5 | INTERFERON BETA-1A | 14 |
| 6 | METHOTREXATE | 14 |
| 7 | METHOTREXATE SODIUM | 14 |
| 8 | SODIUM OXYBATE | 13 |
| 9 | ACETAMINOPHEN | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 1 | RESLIZUMAB | 1 | 0.0015 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 4 | 0.0014 |
| 3 | CEFPROZIL | 1 | 0.0013 |
| 4 | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | 1 | 0.0012 |
| 5 | MECASERMIN | 1 | 0.0012 |
| 6 | CEFADROXIL | 2 | 0.0010 |
| 7 | ADALIMUMAB-AFZB | 2 | 0.0007 |
| 8 | CLEMASTINE FUMARATE | 1 | 0.0007 |
| 9 | ETONOGESTREL AND ETHINYL ESTRADIOL | 15 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 42 |
| 1 | Estrogen [EPC] | 28 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 3 | Benzodiazepine [EPC] | 19 |
| 4 | Corticosteroid [EPC] | 18 |
| 5 | Janus Kinase Inhibitor [EPC] | 17 |
| 6 | Progestin [EPC] | 17 |
| 7 | GLP-1 Receptor Agonist [EPC] | 16 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 9 | Interferon beta [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 3 | Estrogen [EPC] | 28 | 0.0001 |
| 4 | Potassium-sparing Diuretic [EPC] | 2 | 0.0001 |
| 5 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 6 | Janus Kinase Inhibitor [EPC] | 17 | 0.0001 |
| 7 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 8 | Sympathomimetic-like Agent [EPC] | 3 | 0.0001 |
| 9 | Sulfone [EPC] | 1 | 0.0001 |